This site is intended for health professionals only

Editor’s pick

Treatment ‘extends cancer survival’
Treatment ‘extends cancer survival’
Systagenix appoints new medical director
Systagenix appoints new medical director
New study transforms DNA sequencing
New study transforms DNA sequencing
Cerner clients connect to fight spread of influenza
Cerner clients connect to fight spread of influenza
Novartis gains exclusive worldwide rights to PTK 0796
Novartis gains exclusive worldwide rights to PTK 0796
Arthritis drug may be too expensive
Arthritis drug may be too expensive
Leukaemia drugs to target genes
Leukaemia drugs to target genes
IDEA updates on Diractin status
IDEA updates on Diractin status
Medicine mistakes at care homes
Medicine mistakes at care homes
Vaccine may stop cocaine addiction
Vaccine may stop cocaine addiction
Onglyza receives European marketing authorisation
Onglyza receives European marketing authorisation
Novartis completes shipment of Fluvirin
Novartis completes shipment of Fluvirin
1 … 108 109 110 111 112 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x